Advances in treatment of dilated cardiomyopathy

Dilated cardiomyopathy (DCM) is defined as a unilateral or bilateral expanded chambers of the heart accompanied by cardiac hypertrophy and myocardial systolic dysfunction, with or without heart failure. The incidence of DCM increases gradually, with the cause being unknown and without specific treatment. Mortality rate is higher and prognosis is poorer, and human health is being seriously compromised. This article systematically reviews current methods of treatment for DCM.